Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do NSAIDs prevent colorectal cancer?

N Arber1

  • 1Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel. nadir@tasmc.health.gov.il

Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|May 8, 2000
PubMed
Summary

Acetylsalicylic acid (ASA) and NSAIDs significantly lower colorectal cancer risk, supported by animal and human studies. Further research is needed to determine optimal dosage for cancer prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A reference model of circulating hematopoietic stem cells across the lifespan with applications to diagnostics.

Nature medicine·2025
Same author

Corrigendum: methotrexate in chronic active Crohn's disease: a double-blind, randomized, israeli multicenter trial.

The American journal of gastroenterology·2015
Same author

Peptides for diagnosis and treatment of colorectal cancer.

Current medicinal chemistry·2014
Same author

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.

Lancet (London, England)·2013
Same author

Gene therapy of pancreatic cancer targeting the K-Ras oncogene.

Cancer gene therapy·2012
Same author

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

Area of Science:

  • Oncology
  • Pharmacology
  • Gastroenterology

Background:

  • Growing evidence suggests acetylsalicylic acid (ASA) and nonsteroidal anti-inflammatory drugs (NSAIDs) decrease colorectal cancer risk.
  • Both animal models and human studies consistently support this chemopreventive effect.
  • Intervention data indicates NSAIDs impact human colonic adenoma polyp formation.

Purpose of the Study:

  • To review the evidence for NSAID-induced chemoprevention of colorectal cancer.
  • To explore the consistency and scope of findings across different study types and populations.
  • To identify the need for further research into optimal dosing and mechanisms.

Main Methods:

  • Systematic review of epidemiological, clinical, and experimental data.
  • Analysis of human studies including case-control and cohort designs.
  • Evaluation of animal studies demonstrating reduced tumor incidence.

Main Results:

  • 21 out of 23 human studies support a reduced risk of colorectal cancer with ASA and NSAID use.
  • Risk reduction observed in both men and women, for colon and rectal cancers.
  • Findings are consistent across various NSAIDs and are unlikely due to earlier lesion detection from drug-induced bleeding.

Conclusions:

  • Consistent epidemiological, clinical, and experimental data support the chemopreventive role of NSAIDs in colorectal cancer.
  • No further placebo trials are necessary due to the strength of existing evidence.
  • Research should now focus on establishing optimal dose, duration, and frequency for cancer prevention.

Related Experiment Videos